Liyuan Tao

Prof. Dr. Liyuan Tao

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2021 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Closed access
Liyuan TaoLiyuan Tao
Liyuan Tao
RWRuitong Wang
Ruitong Wang
NHNa Han
Na Han
JLJihong Liu
Jihong Liu
CYChuanxiang Yuan
Chuanxiang Yuan
Jue LiuJue Liu
Jue Liu
Background: Vaccine hesitancy has been recognized as an urgent public health issue. We aimed to explore the acceptance of a COVID-19 vaccine and related factors among pregnant women, a vulnerable population for vaccine-preventable diseases. Methods: A multi-center cross-sectional study among pregnant women was conducted in five provinces of mainland China from November 13 to 27, 2020. We collected sociodemographic characteristics, attitude, knowledge, and health beliefs on COVID-19 vaccination. Locally weighted scatterplot smoothing regression analysis was used to assess the trends of vaccination acceptance. Multivariable logistic regression was performed to identify factors related to vaccination acceptance. Results: Among the 1392 pregnant women, the acceptance rate of a COVID-19 vaccine were 77.4% (95%CI 75.1–79.5%). In the multivariable regression model, the acceptance rate was associated with young age (aOR = 1.87, 95% CI: 1.20–2.93), western region (aOR = 2.73, 95% CI: 1.72–4.32), low level of education (aOR = 2.49, 95% CI: 1.13–5.51), late pregnancy (aOR = 1.49, 95% CI: 1.03–2.16), high knowledge score on COVID-19 (aOR = 1.05, 95% CI: 1.01–1.10), high level of perceived susceptibility (aOR = 2.18, 95% CI: 1.36–3.49), low level of perceived barriers (aOR = 4.76, 95% CI: 2.23–10.18), high level of perceived benefit (aOR = 2.18, 95% CI: 1.36–3.49), and high level of perceived cues to action (aOR = 15.70, 95% CI: 8.28–29.80). Conclusions: About one quarters of pregnant women have vaccine hesitancy. Our findings highlight that targeted and multipronged efforts are needed to build vaccine literacy and confidence to increase the acceptance of a COVID-19 vaccine during the COVID-19 pandemic, especially for vulnerable populations.

9 December 2019 in Journal of Cardiovascular Translational Research
Verified
Journal Article
Open access
PDF file
YSYanxin Song
Yanxin Song
CRChuan Ren
Chuan Ren
PLPing Liu
Ping Liu
Liyuan TaoLiyuan Tao
Liyuan Tao
WZWei Zhao
Wei Zhao
WGWei Gao
Wei Gao
The aim of this study was to investigate the effects of telemonitored exercise rehabilitation on patients with coronary heart disease (CHD) in China. Ninety-six patients with stable CHD were included and analyzed (48 in telemonitored group and 48 in control group). All patients received routine follow-up, and patients in telemonitored group participated in smartphone-based telemonitored cardiac rehabilitation. Patients’ demographic information, medical history, diagnosis and treatment of CHD, and laboratory results were collected. The difference of cardiopulmonary exercise testing (CPET), blood test, and echocardiographic parameters; exercise habits; control rate of blood lipid and blood glucose; and incidence of adverse events between the two groups during 6 months of follow-up was analyzed. After intervention, the subjects in the telemonitored group performed significantly better in VO2peak, exercise compliance, and some other parameters than those in the control group. Telemonitored exercise rehabilitation is an effective rehabilitation mode for CHD patients in China.

1 September 2017 in BMJ Open
Verified
Journal Article
Open access
PDF file
YLYan Liu
Yan Liu
JYJiarui Yang
Jiarui Yang
Liyuan TaoLiyuan Tao
Liyuan Tao
HLHuibin Lv
Huibin Lv
XJXiaodan Jiang
Xiaodan Jiang
XLXuemin Li
Xuemin Li
Objective To explore the risk factors of diabetic retinopathy (DR) and sight-threatening diabetic retinopathy (STDR) among Chinese patients with diabetes. Design, setting and participants A cross-sectional investigation was performed in eight screening clinics in six provinces across mainland China. Information about the risk factors was recorded in screening clinics. Some risk factors (sex, age, diagnosis age, diabetes duration, systolic blood pressure (SBP), diastolic blood pressure, fasting blood glucose (FBG) and glycosylated haemoglobin (HbA1c)) were recorded in all eight clinics, while others were collected only in a subset of the clinics. The relationships between the risk factors and DR and between the risk factors and STDR were explored for the eight factors mentioned above and for all factors studied. Main outcomes and measures Risk factors of DR and STDR were assessed, and a nomogram of the results was produced. Results Younger age, longer diabetes duration, higher SBP, higher FBG and higher HbA1c were found to be independent risk factors for both DR and STDR in the eight-factor analyses. In the all-factor analysis, younger age, longer diabetes duration, higher SBP, oral medicine use and insulin use were independent risk factors for both DR and STDR; higher postprandial blood glucose (PBG), HbA1c, triglyceride andlow-density lipoprotein were independent risk factors for DR only, and higher FBG was a risk factor for STDR only. Conclusions In this cross-sectional investigation, several risk factors were found for DR and STDR. Notably, FBG, PBG and HbA1c were all risk factors for DR or STDR, suggesting that stricter blood glucose control in clinical practice is required.

7 January 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
Chenyuan QinChenyuan Qin
Chenyuan Qin
RWRuitong Wang
Ruitong Wang
Liyuan TaoLiyuan Tao
Liyuan Tao
MLMin Liu
Min Liu
Jue LiuJue Liu
Jue Liu
COVID-19 infections are returning to many countries because of the emergence of variants or declining antibody levels provided by vaccines. An additional dose of vaccination is recommended to be a considerable supplementary intervention. We aim to explore public acceptance of the third dose of the COVID-19 vaccine and related influencing factors in China. This nationwide cross-sectional study was conducted in the general population among 31 provinces in November, 2021. We collected information on basic characteristics, vaccination knowledge and attitudes, and vaccine-related health beliefs of the participants. Univariable and multivariable logistic regression models were used to assess factors associated with the acceptance of a third COVID-19 vaccine. A total of 93.7% (95% CI: 92.9–94.6%) of 3119 Chinese residents were willing to receive a third dose of the COVID-19 vaccine. Individuals with low level of perceived susceptibility, perceived benefit, cues to action cues, and high level of perceived barriers, old age, low educational level, low monthly household income, and low knowledge score on COVID-19 were less likely to have the acceptance of a third dose of COVID-19 (all p < 0.05). In the multivariable logistic regression model, acceptance of the third dose of COVID-19 vaccine was mainly related to previous vaccination history [Sinopharm BBIP (aOR = 6.55, 95% CI 3.30–12.98), Sinovac (aOR = 5.22, 95% CI:2.72–10.02), Convidecia (aOR = 5.80, 95% CI: 2.04–16.48)], high level of perceived susceptibility (aOR = 2.48, 95% CI: 1.48–4.31) and high level of action cues (aOR = 23.66, 95% CI: 9.97–56.23). Overall, residents in China showed a high willingness to accept the third dose of COVID-19 vaccines, which can help vaccine manufacturers in China to manage the vaccine production and distribution for the huge domestic and international vaccine demand. Relevant institutions could increase people’s willingness to booster shots by increasing initial COVID-19 vaccination rates, public’s perception of COVID-19 susceptibility and cues to action through various strategies and channels. Meanwhile, it also has certain reference significance for other countries to formulate vaccine promotion strategies.

7 September 2023 in British Journal of Anaesthesia
Verified
Journal Article
Open access
WGWan-Jie Gu
Wan-Jie Gu
XDXiang-Jie Duan
Xiang-Jie Duan
XLXiao-Zhu Liu
Xiao-Zhu Liu
YCYun Cen
Yun Cen
Liyuan TaoLiyuan Tao
Liyuan Tao
HYHaiyan Yin
Haiyan Yin
Trials have demonstrated lower rates of acute kidney injury in critically ill patients receiving magnesium supplementation, but they have yielded conflicting results regarding mortality. This is a retrospective cohort study based on the MIMIC-IV (Medical Information Mart in Intensive Care-IV) database. Adult critically ill patients with sepsis were included in the analysis. The exposure was magnesium sulfate use during ICU stay. The primary outcome was 28-day all-cause mortality. Propensity score matching (PSM) was conducted at a 1:1 ratio. Multivariable analyses were used to adjust for confounders. The pre-matched and propensity score-matched cohorts included 10 999 and 6052 patients, respectively. In the PSM analysis, 28-day all-cause mortality rate was 20.2% (611/3026) in the magnesium sulfate use group and 25.0% (757/3026) in the no use group. Magnesium sulfate use was associated with lower 28-day all-cause mortality (hazard ratio [HR], 0.70; 95% CI, 0.61-0.79; P<0.001). Lower mortality was observed regardless of baseline serum magnesium status: for hypomagnesaemia, HR, 0.64; 95% confidence interval (CI), 0.45-0.93; P=0.020; for normomagnesaemia, HR, 0.70; 95% CI, 0.61-0.80; P<0.001. Magnesium sulfate use was also associated with lower ICU mortality (odds ratio [OR], 0.52; 95% CI, 0.42-0.64; P<0.001), lower in-hospital mortality (OR, 0.65; 95% CI, 0.55-0.77; P<0.001), and renal replacement therapy (OR, 0.67; 95% CI, 0.52-0.87; P=0.002). A sensitivity analysis using the entire cohort also demonstrated lower 28-day all-cause mortality (HR, 0.62; 95% CI, 0.56-0.69; P<0.001). Magnesium sulfate use was associated with lower mortality in critically ill patients with sepsis. Prospective studies are needed to verify this finding.

8 August 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
QDQianqian Dai
Qianqian Dai
MLMing Li
Ming Li
MYMaoshu Yang
Maoshu Yang
SSShiwu Shi
Shiwu Shi
ZWZhaoyu Wang
Zhaoyu Wang
YTYi-da Tang
Yi-da Tang
Background: Artificial intelligence (AI) has demonstrated transformative potential in the health care field; yet, its clinical adoption faces challenges such as inaccuracy, bias, and data privacy concerns. As the primary operators of AI systems, physicians and nurses play a pivotal role in integrating AI into clinical workflows. Their acceptance and use of AI are essential for bridging the gap between technological innovation and practical implementation. Exploring Chinese medical staff’s attitudes and identifying key factors influencing AI adoption are fundamental to developing targeted strategies to facilitate the effective application of AI in clinical settings. Objective: This study aims to investigate attitudes and perceptions regarding medical AI among physicians and nurses in China and identify the factors influencing its adoption. Methods: A nationwide cross-sectional survey was conducted online from December 12 to 26, 2024. Participants were recruited from the Chinese Medical Association and the Chinese Nursing Association. The structured questionnaire assessed demographic characteristics, knowledge and attitudes toward medical AI, experiences and insights regarding using medical AI, and perceptions and factors influencing the adoption of AI based on the unified theory of acceptance and use of technology (UTAUT) model. Multiple linear regression and Karlson-Holm-Breen mediation analysis were used to identify influencing factors. Sample weighting by regional distribution was applied for sensitivity analysis. Results: The survey included 991 physicians and 1714 nurses. Among the respondents, 92.4% (916/991) of the physicians and 84.19% (1443/1714) of the nurses reported awareness of medical AI applications, 22.8% (226/991) of the physicians and 17% (291/1714) of the nurses had used AI, and 82.6% (819/991) of the physicians and 80.22% (1375/1714) of the nurses held optimistic views about AI’s prospects. After adjusting for covariates, performance expectancy (physicians: B=0.144, 95% CI 0.092-0.197; nurses: B=0.292, 95% CI 0.245-0.338), effort expectancy (physicians: B=0.681, 95% CI 0.562-0.800; nurses: B=0.440, 95% CI 0.342-0.538), social influence (physicians: B=0.264, 95% CI 0.187-0.341; nurses: B=0.098, 95% CI 0.045-0.152), and facilitating conditions (physicians: B=0.098, 95% CI 0.030-0.165; nurses: B=0.158, 95% CI 0.105-0.212) had significant positive impacts on willingness to use AI. Perceived risk showed no significant effect on physicians’ intention to use AI (B=0.012, 95% CI −0.022 to 0.045) but negatively impacted nurses’ intention to use AI (B=−0.041, 95% CI −0.066 to −0.015). Performance expectancy and effort expectancy partially mediated the relationship between facilitating conditions and intention to use. Age, educational level, hospital level, work experience, and personal views also significantly influenced willingness. Weighted and unweighted analyses yielded consistent results, confirming the robustness of the findings. Conclusions: Substantial disparities exist between high willingness to adopt medical AI and its low actual use among Chinese medical staff. System optimization focusing on utility enhancement, workflow integration, and risk mitigation for medical staff, along with support for infrastructure and training, could accelerate AI adoption in clinical practice.